Diabyuda
PrivateLast Round
Grant
Jun 23, 2025
Company Overview
Diabyuda is a health technology company that develops an AI-powered clinical decision support system to personalize treatment plans for patients with type 2 diabetes and its comorbidities.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diabyuda Comparables
Compare Diabyuda with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| decide Clinical Software GmbH | 83% | |
| DreaMed | 79% | |
| Health Recovery Solutions | 78% |
Diabyuda Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 23, 2025 |
Diabyuda Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EIT Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2025
$70K grant received from EIT Health.
Diabyuda Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Diabyuda's valuation, stock price, and market status.
Is Diabyuda a public or private company?
Diabyuda is a private company.
What is the current stock price of Diabyuda?
Diabyuda is a private company with no public stock price. Caplight tracks Diabyuda's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Diabyuda worth (valuation)?
Valuation information for Diabyuda is not publicly available.
Can I buy Diabyuda stock?
Diabyuda shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Diabyuda's last funding round?
Diabyuda's most recent funding round was Grant on June 23, 2025.
Who are the main investors in Diabyuda?
Key investors in Diabyuda include EIT Health.
Will Diabyuda IPO soon?
No public IPO plans have been announced for Diabyuda.
How can I track Diabyuda secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Diabyuda's secondary market activity and sign up for updates.